LGALS1 overexpression + LAG3 overexpression
|
CLL
|
LGALS1 overexpression + LAG3 overexpression
|
CLL
|
ibrutinib Resistant: C3 – Early Trials
|
ibrutinib Resistant: C3 – Early Trials
|
LGALS1 overexpression + LAG3 overexpression
|
CLL
|
LGALS1 overexpression + LAG3 overexpression
|
CLL
|
OTX-008 Sensitive: C3 – Early Trials
|
OTX-008 Sensitive: C3 – Early Trials
|